2023-01-25 17:01:00

Here's How Much $1000 Invested In Catalyst Pharmaceuticals 15 Years Ago Would Be Worth Today

Logo Benzinga
Benzinga
By Benzinga Insights

Catalyst Pharmaceuticals CPRX has outperformed the market over the past 15 years by 3.88% on an annualized basis producing an average annual return of 11.2%. Currently, Catalyst Pharmaceuticals has a market capitalization of $1.72 billion.

Buying $1000 In CPRX: If an investor had bought $1000 of CPRX stock 15 years ago, it would be worth $4,946.11 today based on a price of $16.50 for CPRX at the time of writing.

Catalyst Pharmaceuticals's Performance Over Last 15 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

Continue read on benzinga.com

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-23 15:34:33
Catalyst Pharmaceuticals CPRX has outperformed the market over the past 10 years by 29.37% on an annualized basis producing an average annual return of...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 16:01:04
UnitedHealth Group UNH has outperformed the market over the past 20 years by 9.01% on an annualized basis producing an average annual return of 16.91%....

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 14:00:38
Tesla TSLA has outperformed the market over the past 10 years by 39.34% on an annualized basis producing an average annual return of 49.5%. Currently, Tesla...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 16:30:35
Meta Platforms META has outperformed the market over the past 10 years by 6.34% on an annualized basis producing an average annual return of 16.47%....

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 14:30:35
Netflix NFLX has outperformed the market over the past 15 years by 28.65% on an annualized basis producing an average annual return of 35.97%. Currently,...

Logo GlobeNewswire
SciencePress Release2023-01-25 02:19:00
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc.(Nasdaq: PLRX), a clinical stage biotechnology company focused on...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 14:00:43
Apple AAPL has outperformed the market over the past 10 years by 13.89% on an annualized basis producing an average annual return of 24.04%. Currently, Apple...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 16:00:59
Boeing BA has outperformed the market over the past 20 years by 2.02% on an annualized basis producing an average annual return of 9.92%. Currently, Boeing...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 16:30:41
GameStop GME has outperformed the market over the past 5 years by 29.35% on an annualized basis producing an average annual return of 36.36%. Currently,...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 15:00:46
Microsoft MSFT has outperformed the market over the past 5 years by 13.17% on an annualized basis producing an average annual return of 20.22%. Currently,...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 15:00:40
NVIDIA NVDA has outperformed the market over the past 10 years by 40.94% on an annualized basis producing an average annual return of 51.09%. Currently,...

Logo Nasdaq
Business / FinanceBy The Motley Fool2023-01-25 11:17:00
Obviously, if we knew with certainty which stocks are going to deliver 10-bagger returns over the next decade, investing would be easy and we'd all get rich....

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 15:30:33
Advanced Micro Devices AMD has outperformed the market over the past 5 years by 34.23% on an annualized basis producing an average annual return of 41.2%....

Logo GlobeNewswire
SciencePress Release2023-01-25 13:03:00
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 15:30:37
Alphabet GOOGL has outperformed the market over the past 15 years by 6.19% on an annualized basis producing an average annual return of 13.48%. Currently,...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-19 17:33:12
TG Therapeutics TGTX has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 12.05%....

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-24 14:04:43
Crown Castle CCI has outperformed the market over the past 20 years by 11.76% on an annualized basis producing an average annual return of 19.73%. Currently,...

Logo GlobeNewswire
EconomyPress Release2023-01-25 12:10:00
Vinyl Chloride Monomer industry is anticipated to register 7.5% CAGR between 2023 and 2032 owing to increasing use of vinyl chloride monomer in the...

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 16:02:19
Xerox Holdings XRX is set to give its latest quarterly earnings report on Thursday, 2023-01-26. Here's what investors need to know before the announcement....

Logo Benzinga
Business / FinanceBy Benzinga Insights2023-01-25 17:01:06
Lockheed Martin LMT has outperformed the market over the past 15 years by 2.64% on an annualized basis producing an average annual return of 9.95%....